Inventor · disambiguated record
Jessica Lynn Seitzer
Also filed as: SEITZER JESSICA · SEITZER JESSICA LYNN
4 granted patents·9 pending applications·4 citations·filing 2016–2025
65Inventor score
Top patents by PatentIndex Score
13 records- 0189US11795460B2Compositions and methods for TTR gene editing and treating ATTR amyloidosisINTELLIA THERAPEUTICS INC·Filed 2022·Granted Oct 24, 2023·1 cites·24 claims
- 0287US9828601B2Compositions for inhibiting checkpoint gene expression and uses thereofIDERA PHARMACEUTICALS INC·Filed 2016·Granted Nov 28, 2017·3 cites·17 claims
- 0381US2025207130A1Compositions and Methods for TTR Gene Editing and Treating ATTR AmyloidosisINTELLIA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0477US11965165B2Compositions and methods for TTR gene editing and treating ATTR amyloidosisINTELLIA THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·0 cites·21 claims
- 0577US2024018496A1Compositions and Methods for Kallikrein (KLKB1) Gene EditingINTELLIA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0672US2023295587A1Compositions and Methods for Kallikrein (KLKB1) Gene EditingINTELLIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0771US2024124897A1Compositions and Methods Comprising a TTR Guide RNA and a Polynucleotide Encoding an RNA-Guided DNA Binding AgentINTELLIA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0870US12480109B2Compositions and methods for kallikrein (KLKB1) gene editingINTELLIA THERAPEUTICS INC·Filed 2025·Granted Nov 25, 2025·0 cites·27 claims
- 0963US2020248180A1Compositions and Methods for TTR Gene Editing and Treating ATTR AmyloidosisINTELLIA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1062US2023044994A1Compositions and Methods Comprising a TTR Guide RNA and a Polynucleotide Encoding an RNA-Guided DNA Binding AgentINTELLIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1155US2023035659A1Compositions and Methods for TTR Gene Editing and Treating ATTR Amyloidosis Comprising a Corticosteroid or Use ThereofINTELLIA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1253US2021087568A1Modified Guide RNAs for Gene EditingINTELLIA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1352US2018044669A1Compositions for inhibiting checkpoint gene expression and uses thereofIDERA PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →